Essential Tremor Treatment with Ultrasound Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2032
Overview
Global Essential Tremor Treatment with Ultrasound Market was valued at USD 1.38 Bn in 2025 and is expected to reach USD 1.67 Bn by 2032, at a CAGR of 2.8% during the forecast period.
Global Essential Tremor Treatment with Ultrasound Market Overview:
Essential tremor is a neurological disorder, which causes involuntary and rhythmic shaking and can affect almost any part of the body, but most commonly in hands especially doing simple tasks such as drinking water from glass or tying shoelaces. Adult population is the most commonly affected, and its prevalence reaches up to 9% in people older than 60 years of age.
To know about the Research Methodology :- Request Free Sample Report
Essential Tremor Treatment with Ultrasound Market Dynamics:
Increasing number of neurological disorders is the major driving factor for market growth
Increasing patient pool for neurological disorders like dementia, epilepsy, tremor, and Parkinson’s diseases drives the demand for ultrasound treatment. According to the Neurological Society of India, approximately 2.3% of the global population suffers from neurological disorders. Until recently these were treated using drugs and surgical procedures, but the growing demand for non-invasive solutions and healthcare investments boost the adoption of ultrasound stimulation alternatives. However, the lack of skilled professionals in some underdeveloped economies as there is the possibility of tissue damage after ultrasound treatment may hamper the market growth.
The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.
Essential Tremor Treatment with Ultrasound Market Segment Analysis:
In 2025, the Head segment shows the highest demand for ultrasound treatment. Tremors in the head, particularly affecting the hypothalamus, are most common and critically impact daily activities. Treatments targeting the Upper Extremity (hands and arms) also show significant demand, given the prevalence of tremors interfering with tasks like drinking or writing. Trunk and Lower Extremity segments represent smaller shares but remain clinically relevant for patients with broader tremor involvement. Overall, the Head segment dominates due to the critical nature of neurological impact and the availability of advanced MRI-guided devices like InSightec’s ExAblate Neuro.
Among end-users, Hospitals hold the largest share in 2025, driven by access to advanced imaging equipment, specialized staff, and the ability to perform MRI-guided ultrasound treatments. Ambulatory Surgical Centers (ASCs) are a growing segment, increasingly adopting minimally invasive procedures for faster patient recovery and lower costs. Clinics and specialty neurology centers contribute to a smaller portion of the market, primarily focused on outpatient or experimental therapies.
Essential Tremor Treatment with Ultrasound Market Regional Insights:
North America leads the global market in 2025 due to technological advancement, early adoption of MRI-guided ultrasound treatments, and high prevalence of neurological disorders. Asia Pacific (APAC) is the fastest-growing region, driven by population growth, rising awareness of non-invasive treatment options, modernization of medical infrastructure, and favorable government policies in countries like India, China, and Japan. Europe maintains moderate demand due to established healthcare systems and R&D in medical devices. Other regions, including Middle East & Africa (MEA) and South America, exhibit smaller but growing adoption, influenced by healthcare infrastructure development and increasing awareness of essential tremor treatments.
The report also helps in understanding Global Essential Tremor Treatment with Ultrasound Market dynamics, structure by analyzing the market segments and project the Global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.
Essential Tremor Treatment with Ultrasound Market report Scope: Inquire before buying
| Global Essential Tremor Treatment with Ultrasound Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 1.38 USD Bn |
| Forecast Period 2026-2032 CAGR: | 2.8% | Market Size in 2032: | 1.67 USD Bn |
| Segments Covered: | by Indication | Head Trunk Upper Extremity Lower Extremity |
|
| by End users | Hospitals Ambulatory Surgical Centers |
||
Essential Tremor Treatment with Ultrasound Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 17 December 2025 | Insightec | Insightec announced the spin-out and launch of Lotus Neuro, a clinical-stage biotechnology company focused on pairing focused ultrasound with advanced brain-targeted therapeutics. | This strategic move accelerates the development of combination therapies that utilize ultrasound to open the blood-brain barrier for drug delivery in complex neurological conditions. |
| 19 November 2025 | Insightec / European Union | At the second Essential Tremor (ET) Conference in Brussels, stakeholders urged the EU to formally recognize ET as a distinct disease to improve patient access to innovative care. | The advocacy aims to end fragmented reimbursement schemes across Europe, potentially expanding the market for incisionless focused ultrasound procedures guided by MRI. |
| 16 September 2025 | Insightec | Insightec highlighted the successful treatment of Lord Julian Fellowes, creator of Downton Abbey, using incisionless MR-guided focused ultrasound for his essential tremor. | High-profile patient advocacy is expected to significantly increase public awareness and diagnostic rates for a condition where 97% of eligible patients currently do not receive advanced therapy. |
| 08 July 2025 | Insightec | The company received FDA approval for staged bilateral focused ultrasound treatment, allowing for the treatment of both sides of the brain in patients with Parkinson's and tremors. | This regulatory milestone expands the total addressable market by offering a complete non-invasive solution for patients suffering from bilateral symptoms. |
| 04 March 2025 | Insightec / Vattikuti Foundation | Insightec and the Vattikuti Foundation partnered with the All India Institute of Medical Sciences (AIIMS) to deploy MR-guided focused ultrasound in India. | The initiative is designed to drastically reduce treatment costs and improve specialized neurological care access in the Asia-Pacific region, a key growth market. |
| 28 January 2025 | Insightec | Insightec secured $150 million in financing to fund continued growth and the expansion of its Exablate Neuro platform globally. | The capital infusion supports R&D for new indications and the commercial scaling of high-intensity focused ultrasound (HIFU) systems in hospitals worldwide. |
Key Players/Competitors Profile, Covered in Global Essential Tremor Treatment with Ultrasound Market Report, From A Strategic Perspective.
- InSightec Ltd.
- Merz Pharma GmbH and Co KgaA
- Neurocrine Biosciences Inc
- Sage Therapeutics Inc
- Dopa Solutions
- Sunset Neurological & Psychiatry Group
- SoniModul, Center for Ultrasound Functional Neurosurgery
- International Medical Center VS Buzaev Memorial
- Mayo Clinic
- UVA Health System
- Siemens AG
- Philips Healthcare
- BrainSonix Corporation
- Sonic Concepts Inc.
- Medtronic plc
- Boston Scientific Corporation
- GE Healthcare
- Elekta AB
- Profound Medical Corp.
- Chongqing Haifu Medical Technology Co., Ltd.
- Theraclion SA
- FUS Instruments
- Alpinion Medical Systems Co., Ltd.
- SonaCare Medical, LLC
- Kona Medical, Inc.